271 related articles for article (PubMed ID: 17545685)
1. Human MD-2 discrimination of meningococcal lipid A structures and activation of TLR4.
Zimmer SM; Zughaier SM; Tzeng YL; Stephens DS
Glycobiology; 2007 Aug; 17(8):847-56. PubMed ID: 17545685
[TBL] [Abstract][Full Text] [Related]
2. Hexa-acylation and KDO(2)-glycosylation determine the specific immunostimulatory activity of Neisseria meningitidis lipid A for human monocyte derived dendritic cells.
Zughaier S; Agrawal S; Stephens DS; Pulendran B
Vaccine; 2006 Feb; 24(9):1291-7. PubMed ID: 16246469
[TBL] [Abstract][Full Text] [Related]
3. Neisseria meningitidis lipooligosaccharide structure-dependent activation of the macrophage CD14/Toll-like receptor 4 pathway.
Zughaier SM; Tzeng YL; Zimmer SM; Datta A; Carlson RW; Stephens DS
Infect Immun; 2004 Jan; 72(1):371-80. PubMed ID: 14688118
[TBL] [Abstract][Full Text] [Related]
4. Stable transduction of bovine TLR4 and bovine MD-2 into LPS-nonresponsive cells and soluble CD14 promote the ability to respond to LPS.
Sauter KS; Brcic M; Franchini M; Jungi TW
Vet Immunol Immunopathol; 2007 Jul; 118(1-2):92-104. PubMed ID: 17559944
[TBL] [Abstract][Full Text] [Related]
5. Monomeric endotoxin:protein complexes are essential for TLR4-dependent cell activation.
Gioannini TL; Teghanemt A; Zhang D; Levis EN; Weiss JP
J Endotoxin Res; 2005; 11(2):117-23. PubMed ID: 15949139
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of truncated human lipopolysaccharide-binding protein in Escherichia coli.
Kohara J; Tsuneyoshi N; Gauchat JF; Kimoto M; Fukudome K
Protein Expr Purif; 2006 Oct; 49(2):276-83. PubMed ID: 16839777
[TBL] [Abstract][Full Text] [Related]
7. Penta-acylated lipopolisaccharide binds to murine MD-2 but does not induce the oligomerization of TLR4 required for signal transduction.
Tsuneyoshi N; Kohara J; Bahrun U; Saitoh S; Akashi S; Gauchat JF; Kimoto M; Fukudome K
Cell Immunol; 2006 Nov; 244(1):57-64. PubMed ID: 17420011
[TBL] [Abstract][Full Text] [Related]
8. Lipid A antagonist, lipid IVa, is distinct from lipid A in interaction with Toll-like receptor 4 (TLR4)-MD-2 and ligand-induced TLR4 oligomerization.
Saitoh S; Akashi S; Yamada T; Tanimura N; Kobayashi M; Konno K; Matsumoto F; Fukase K; Kusumoto S; Nagai Y; Kusumoto Y; Kosugi A; Miyake K
Int Immunol; 2004 Jul; 16(7):961-9. PubMed ID: 15184344
[TBL] [Abstract][Full Text] [Related]
9. Human Toll-like receptor 4 recognizes host-specific LPS modifications.
Hajjar AM; Ernst RK; Tsai JH; Wilson CB; Miller SI
Nat Immunol; 2002 Apr; 3(4):354-9. PubMed ID: 11912497
[TBL] [Abstract][Full Text] [Related]
10. Regulation of interactions of endotoxin with host cells.
Gioannini TL; Teghanemt A; Zarember KA; Weiss JP
J Endotoxin Res; 2003; 9(6):401-8. PubMed ID: 14733729
[TBL] [Abstract][Full Text] [Related]
11. Neisseria meningitidis type C capsular polysaccharide inhibits lipooligosaccharide-induced cell activation by binding to CD14.
Kocabas C; Katsenelson N; Kanswal S; Kennedy MN; Cui X; Blake MS; Segal DM; Akkoyunlu M
Cell Microbiol; 2007 May; 9(5):1297-310. PubMed ID: 17250593
[TBL] [Abstract][Full Text] [Related]
12. Activation of human meningeal cells is modulated by lipopolysaccharide (LPS) and non-LPS components of Neisseria meningitidis and is independent of Toll-like receptor (TLR)4 and TLR2 signalling.
Humphries HE; Triantafilou M; Makepeace BL; Heckels JE; Triantafilou K; Christodoulides M
Cell Microbiol; 2005 Mar; 7(3):415-30. PubMed ID: 15679844
[TBL] [Abstract][Full Text] [Related]
13. MD-2 binds to bacterial lipopolysaccharide.
Viriyakosol S; Kirkland T; Soldau K; Tobias P
J Endotoxin Res; 2000; 6(6):489-91. PubMed ID: 11521076
[TBL] [Abstract][Full Text] [Related]
14. TLR4-dependent adjuvant activity of Neisseria meningitidis lipid A.
Zughaier S; Steeghs L; van der Ley P; Stephens DS
Vaccine; 2007 May; 25(22):4401-9. PubMed ID: 17466419
[TBL] [Abstract][Full Text] [Related]
15. Neisseria meningitidis lipid A mutant LPSs function as LPS antagonists in humans by inhibiting TLR 4-dependent cytokine production.
Sprong T; Ley Pv; Abdollahi-Roodsaz S; Joosten L; Meer Jv; Netea M; Deuren Mv
Innate Immun; 2011 Dec; 17(6):517-25. PubMed ID: 21088052
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran.
Kim HM; Park BS; Kim JI; Kim SE; Lee J; Oh SC; Enkhbayar P; Matsushima N; Lee H; Yoo OJ; Lee JO
Cell; 2007 Sep; 130(5):906-17. PubMed ID: 17803912
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of Toll-like receptor 4 and myeloid differentiation protein-2 interaction with fluorescence resonance energy transfer].
Liu YW; Liu JH; Tang J; Zhao Q; Li JJ; Zhao MZ; Li ZJ; Wang GJ; Zhong TY; Deng P; Jiang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1101-5. PubMed ID: 16939893
[TBL] [Abstract][Full Text] [Related]
18. Mechanism regulating cell surface expression and activation of Toll-like receptor 4.
Saitoh S; Miyake K
Chem Rec; 2006; 6(6):311-9. PubMed ID: 17304555
[TBL] [Abstract][Full Text] [Related]
19. Bordetella pertussis Lipid A Recognition by Toll-like Receptor 4 and MD-2 Is Dependent on Distinct Charged and Uncharged Interfaces.
Maeshima N; Evans-Atkinson T; Hajjar AM; Fernandez RC
J Biol Chem; 2015 May; 290(21):13440-53. PubMed ID: 25837248
[TBL] [Abstract][Full Text] [Related]
20. Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa.
Ohto U; Fukase K; Miyake K; Satow Y
Science; 2007 Jun; 316(5831):1632-4. PubMed ID: 17569869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
